Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of VASCEPA228.61M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
US product revenue, net166.7M72.92%
Rest of World (RoW) product revenue, net24.23M10.60%
Licensing and royalty revenue24.02M10.51%
Europe product revenue, net13.66M5.98%